
Wilma M Hopman
Articles
-
May 10, 2023 |
ecancer.org | Manju Sengar |Wilma M Hopman |Ghulam Rehman Mohyuddin |Aaron Goodman
How likely is this article to improve patient care in your region? Is reading this article likely to improve your clinical practice? How likely are you to recommend this article to a colleague?
-
May 10, 2023 |
ecancer.org | Manju Sengar |Wilma M Hopman |Ghulam Rehman Mohyuddin |Aaron Goodman
Background: Design, results, and interpretation of oncology randomised controlled trials (RCTs) have changed substantially over the past decade. In this study, we describe all RCTs evaluating anticancer therapies in haematological cancers published globally during 2014–2017 with comparisons with solid tumours RCTs. Methods: A PubMed literature search identified all phase 3 RCTs of anticancer therapy for haematological cancers and solid tumours published globally during 2014–2017.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →